Tumor Treatment
Tumor Treatment - Related Videos
07:16
Thermal Ablation for the Treatment of Abdominal Tumors
0 Views •
Cited by 19 •
2011
A thermal tumor ablation procedure is described. The entire procedure is detailed, including pretreatment planning and imaging studies, anesthesia, adjuvant techniques to facilitate a percutaneous approach, imaging guidance of the ablation device to the tumor, thermal treatment, post-treatment care and follow-up.
06:32
Operating Procedures of the Electrochemotherapy for Treatment of Tumor in Dogs and Cats
0 Views •
Cited by 45 •
2016
Electrochemotherapy is the local treatment of solid tumors. The main mechanism is electroporation-mediated permeabilization of the tumor cells' membrane which enables increased internalization of cytostatics like bleomycin and cisplatin. Thus, antitumor effectiveness is potentiated at the site of the application of electric pulses to the tumors.
07:12
Bioluminescence-Based Tumor Quantification Method for Monitoring Tumor Progression and Treatment Effects in Mouse Lymphoma Models
0 Views •
Cited by 29 •
2016
Bioluminescence imaging is a well-known tool for localizing tumors and metastases, but quantification of these images often requires complex calculations and particular instruments. We describe the easy-to-use luminoscore method, based on precise acquisition conditions, requiring no calculations, and enabling tumor burden and treatment response to be monitored in mouse models.
06:15
Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
0 Views •
Cited by 15 •
2014
A novel methodology that is employed for the treatment of recurrent glioblastomas is described. This treatment approach employs the application of alternating electric tumor treating fields (TTFields), known as TTF Therapy in combination with bevacizumab, a targeted agent that is currently FDA approved as monotherapy.
08:43
An Orthotopic Bladder Tumor Model and the Evaluation of Intravesical saRNA Treatment
0 Views •
Cited by 12 •
2012
Establishing an orthotopic bladder tumor model to evaluate antitumor effects of intravesically delivered saRNA and monitoring tumor growth by ultrasound and bioluminescent imaging.
FAQs
These features help determine whether treatment should focus on the primary tumor, address cancer cells elsewhere, or combine both goals. Tumor type can affect which growth pathways or immune responses are relevant, while stage indicates the extent of disease. Location also shapes whether surgical removal, radiation, systemic therapy, or a combination offers the most appropriate strategy.
Combination regimens bring together therapies with different effects on cancer cells or the tumor environment. This approach can improve tumor control compared with relying on one strategy and may limit the ability of resistant cancer cells to persist. Cancer research evaluates these combinations by examining safety, tumor response, recurrence, and longer-term patient outcomes.
Surgery aims to remove abnormal tissue, whereas radiation damages cancer-cell DNA. Targeted drugs interfere with growth signaling, and immunotherapies seek to activate immune responses against tumor cells. These distinct mechanisms explain why treatment selection depends on tumor characteristics and why combining approaches may provide broader control than using a single modality.
Evaluation extends beyond whether a tumor shrinks. Researchers examine treatment safety, measurable tumor response, recurrence, biomarkers, and patient outcomes. Considering these endpoints together helps distinguish temporary control from more durable benefit and supports comparisons among treatment strategies for particular tumor types, stages, and locations.
Biomarkers are evaluated as part of research seeking more precise tumor treatment. When considered alongside safety findings, tumor response, recurrence, and patient outcomes, they can help characterize how treatment performs in different biological settings. Their inclusion supports efforts to develop therapies that are better matched to tumor features and more durable over time.
Recurrence shows that initial tumor control may not be durable, making it an important outcome in cancer research. Studies therefore assess whether treatment prevents or delays the tumor from returning, not only whether it produces an early response. Findings about recurrence help guide combination regimens and the search for more lasting therapeutic effects.